cached image

Richard J. Wyatt

National Institute of Mental Health, Bethesda, MD, United States 
Schizophrenia, monoamines
"Richard Wyatt"
Mean distance: 13.71 (cluster 17)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Herrell R, Henter ID, Mojtabai R, et al. (2006) First psychiatric hospitalizations in the US military: the National Collaborative Study of Early Psychosis and Suicide (NCSEPS). Psychological Medicine. 36: 1405-15
El-Mallakh RS, Garver D, Holcomb JA, et al. (2005) Post lumbar-puncture headaches in schizophrenic and psychiatrically normal control subjects. Schizophrenia Research. 77: 111-2
Brown AS, Begg MD, Gravenstein S, et al. (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Archives of General Psychiatry. 61: 774-80
Apud JA, Egan MF, Wyatt RJ. (2003) Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. Schizophrenia Research. 63: 151-60
Jones K, Colson PW, Holter MC, et al. (2003) Cost-effectiveness of critical time intervention to reduce homelessness among persons with mental illness. Psychiatric Services (Washington, D.C.). 54: 884-90
Wyatt RJ, Henter ID, Mojtabai R, et al. (2003) Height, weight and body mass index (BMI) in psychiatrically ill US Armed Forces personnel. Psychological Medicine. 33: 363-8
Chrapusta SJ, Egan MF, Wyatt RJ, et al. (2003) Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. Synapse (New York, N.Y.). 47: 270-7
Huang J, Pickel VM. (2002) Differential distribution of 5HT2A and NMDA receptors in single cells within the rat medial nucleus of the solitary tract. Synapse (New York, N.Y.). 44: 64-75
Elkashef AM, Al-Barazi H, Venable D, et al. (2002) Dopamine effect on the mitochondria potential in B lymphocytes of schizophrenic patients and normal controls. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 145-8
van de Laar N, Henter I, Bartko JJ, et al. (2001) Adverse events during a placebo phase for inpatients with chronic schizophrenia. Biological Psychiatry. 50: 487-92
See more...